Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Cheryl Cohen

Director at ImmunityBio, Inc. (IBRX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.1M

Reported trades

Filed Stock Type Shares Price Value Since
Oct 6SEC IBRXImmunityBio, Inc. Sell Plan 81,056100,309 held (−45%) $10.50 $851K -12.6%
Jul 6SEC IBRXImmunityBio, Inc. Sell Plan 131,210125,386 held (−51%) $9.50 $1.2M -3.4%
  • Sell

    Director Cheryl Cohen sold $851K of IBRX at $10.50 — cuts the stake by 45%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Cheryl Cohen sold $1.2M of IBRX at $9.50 — cuts the stake by 51%; pre-scheduled 10b5-1 plan sale.